• Explore /
  • Poster
  • / Liquid biopsy<em> AR</em>/enhancer alteration detection before AR-targeted therapy and correlation with survival in metastatic castrate-resistant prostate cancer patients.

Liquid biopsy AR/enhancer alteration detection before AR-targeted therapy and correlation with survival in metastatic castrate-resistant prostate cancer patients.

Abstract Poster

Authors

null

Alexander Shiang

Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO

Alexander Shiang , Pradeep S. Chauhan , Ha X. Dang , Jace Webster , Elisa M. Ledet , Ramandeep K Babbra , Wenjia Feng , Peter K. Harris , Ellen B. Jaeger , Patrick Miller , Sydney Caputo , Giordano Fabricio Cittolin Santos , Russell Kent Pachynski , A. Oliver Sartor , Christopher Maher , Aadel A Chaudhuri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 171)

DOI

10.1200/JCO.2022.40.6_suppl.171

Abstract #

171

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Justin Shaya

First Author: Christopher Sweeney

First Author: Siyuan S Guo

First Author: Emmanuel S. Antonarakis